UNSPSC 51273817: Camphor/menthol/methyl salicylate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE650. This VA Drug Class (DE650) classifies this compound as belonging to the group ANALGESICS, TOPICAL.

UNSPSC 51273817 Camphor/menthol/methyl salicylate is a Commodity code that captures pharmaceutical and over-the-counter chemical compounds state and local governments procure for health and safety programs, though recent activity shows the code tagged to a broader range of health-related products including naloxone, generic pharmaceuticals, and therapeutic pharmacy initiatives rather than menthol-based items specifically. State and local issuing bodies soliciting under or adjacent to this code include county health departments, state health and human services agencies, and cooperative purchasing alliances serving multiple jurisdictions. Seminole County, Florida (IFB60459723LAS, posted June 30, 2026, due July 26, 2026) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive sealed bidding with quarterly deliveries to the county community health building. The Texas Health and Human Services Commission (RFI HHS0017013, posted April 3, 2026) issued a Request for Information to gather vendor capabilities on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and group purchasing organization channels.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, posted an RFP (S1070000015802, due March 26, 2026) to establish multi-award contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities in Minnesota and Oregon. Vendors must maintain relationships with three authorized wholesalers—AmerisourceBergen (Cencora), Cardinal Health 110 and 112, and Morris & Dickson—and comply with cGMP and Drug Supply Chain Security Act requirements, with contract terms effective July 1, 2026. Recent activity concentrates in Florida and Texas for single-jurisdiction health procurements, while cooperative purchasing vehicles like MMCAP drive multi-state pharmaceutical and OTC product agreements. The code shows modest but meaningful state and local activity focused on pharmaceutical supply, naloxone distribution, and OTC product aggregation rather than narrow menthol-specific chemistry.